Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5GS4

Crystal structure of estrogen receptor alpha in complex with a stabilized peptide antagonist

Summary for 5GS4
Entry DOI10.2210/pdb5gs4/pdb
DescriptorEstrogen receptor, ARG-IAS-ILE-LEU-DNP-ARG-LEU-LEU-GLN, PHOSPHATE ION, ... (5 entities in total)
Functional Keywordsestrogen receptor alpha, stabilized peptide, transcription
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight29327.37
Authors
Xie, M.,Wang, T.,Li, Z.-G. (deposition date: 2016-08-13, release date: 2017-08-30, Last modification date: 2018-07-18)
Primary citationXie, M.,Zhao, H.,Liu, Q.,Zhu, Y.,Yin, F.,Liang, Y.,Jiang, Y.,Wang, D.,Hu, K.,Qin, X.,Wang, Z.,Wu, Y.,Xu, N.,Ye, X.,Wang, T.,Li, Z.
Structural Basis of Inhibition of ER alpha-Coactivator Interaction by High-Affinity N-Terminus Isoaspartic Acid Tethered Helical Peptides
J. Med. Chem., 60:8731-8740, 2017
Cited by
PubMed Abstract: Direct inhibition of the protein-protein interaction of ERα and its endogenous coactivators with a cell permeable stabilized peptide may offer a novel, promising strategy for combating ERα positive breast cancers. Here, we report the co-crystal structure of a helical peptide stabilized by a N-terminal unnatural cross-linked aspartic acid (TD) in complex with the ERα ligand binding domain (LBD). We designed a series of peptides and peptide 6 that showed direct and high-affinity binding to ERα with selective antiproliferative activity in ERα positive breast cancer cells. The co-crystal structure of the TD-stabilized peptide 6 in complex with ERα LBD further demonstrates that it forms an α helical conformation and directly binds at the coactivator binding site of ERα. Further studies showed that peptide 6 could potently inhibit cellular ERα's transcriptional activity. This approach demonstrates the potential of TD stabilized peptides to modulate various intracellular protein-protein interactions involved in a range of disorders.
PubMed: 29045135
DOI: 10.1021/acs.jmedchem.7b00732
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon